FIELD: chemistry.
SUBSTANCE: group of inventions relates to biology, in particular to novel gene of glycerol-3-phosphate-acyltransferase and/or glycerolphosphate - acyltransferase. Invention also relates to protein, coded by said gene, expression vector, containing claimed nucleic acid, and transformant, transformed by said vector. Invention relates to composition of fatty acids, produced by claimed transformant, and to method of obtaining said composition.
EFFECT: group of inventions provides possibility of obtaining fat production with specified composition ratio of fatty acids with provision of increased content of specified fatty acid or increase of amount of spare triacylglycerol (TG) lipid.
9 cl, 11 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF OBTAINING INDUSTRIAL PRODUCTS FROM PLANT LIPIDS | 2015 |
|
RU2743384C2 |
| PLANTS WITH MODIFIED CHARACTERS | 2017 |
|
RU2809117C2 |
| RECOVERED NUCLEIC ACID WHICH CODES FVIII-BDD-BASED FUSION PROTEIN AND HETEROLOGOUS SIGNAL PEPTIDE, AND USE THEREOF | 2022 |
|
RU2818229C2 |
| MUTANT POLYPEPTIDE HYDROXYPHENYLPYRUVATE DIOXYGENASE, CODING GENE THEREOF AND USE THEREOF | 2019 |
|
RU2822892C1 |
| MUTANT NITRILE HYDRATASE, NUCLEIC ACID WHICH ENCODES SAID MUTANT NITRILE HYDRATASE, EXPRESSION VECTOR AND TRANSFORMANT CONTAINING SAID NUCLEIC ACID, METHOD OF PRODUCING SAID MUTANT NITRILE HYDRATASE AND METHOD OF PRODUCING AMIDE COMPOUND | 2017 |
|
RU2736086C1 |
| AAV5-BASED VACCINE FOR INDUCTION OF SPECIFIC IMMUNITY TO SARS-COV-2 VIRUS AND/OR PREVENTION OF CORONAVIRUS INFECTION CAUSED BY SARS-COV-2 | 2020 |
|
RU2760301C1 |
| ANTICANCER VACCINES | 2017 |
|
RU2718663C2 |
| ENZYMATIVE SYNTHESIS OF N-ACETYLNEURAMIC ACID | 2018 |
|
RU2809787C2 |
| RECOMBINASE MUTANTS | 2015 |
|
RU2721920C2 |
| INSECTICIDAL PROTEINS | 2018 |
|
RU2761666C2 |
